SANTHERA PHARMACEUTICALS HOLDING AG (CHF.IMC) — Analyst Meeting

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the SANTHERA full year results presentation. Throughout this recorded meeting, analysts will be in listen only mode. Questions are encouraged, they can be submitted at any time by the q and a tab situated in the right corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question received in the meeting itself. However, the company can view all the questions submitted today and publish responses where it's appropriate to do so. I'd now like to hand you over to Dario Oakland, CEO. Good afternoon to you, sir. Thank you, Alessandro. Welcome to the full year results of the year ending 12/31/2024. Given giving the presentation today will be myself, Daria Eklund. I'm the CEO, as well as our CFO, Katherine Eastead. Our chief medical officer, doctor Shabir Hasham, will also be joining us for the q and a at the end. I'd encourage you to type in your questions, as just mentioned, the q and a box as we go along, so we'll try to answer those questions at the end of this, this call. Should we not be able to answer all those questions that you may have, we will definitely get back to you later after the call. I'd like you to draw your attention to the disclaimer. This is that we will be making forward looking statements. I invite you to please feel free to read this at your leisure. And with that, I'd like to switch our focus now to the overview of SANTHERA PHARMACEUTICALS in general. While we appreciate that this is a results call, we thought it's worth maybe spending a bit of time going through what who is SANTHERA, what we do, especially as some of you were unable to attend our Capital Markets Day recently. So we will be covering off some of the key slides we presented at the...